The focus of this study was to examine the clinical significance of peripheral interleukins (IL-1β, IL-2, IL-6, and IL-10) in previously untreated patients with FEDN psychosis, by comparing them with the healthy controls and by analysing their association with symptoms assessed using the PANSS scale. This evidence concerns the gene IL2 and psychotic disorder.